Lancet report highlights gaps in immunisation—no routine vaccine for 14.4 lakh Indian kids in 2023
The report—published in The Lancet Wednesday—said that in 2023, more than half of the 1.57 crore unvaccinated children worldwide were living in just eight countries, primarily in sub-Saharan Africa (53 percent) and South Asia (13 percent).
New Delhi: Nearly 14.4 lakh children in India did not receive a single shot of any routine vaccine in 2023, with the country recording the second-highest 'zero dose' kids, according to a new and significant analysis by the Global Burden of Disease Study Vaccine Coverage Collaborators.
The lack of immunisation against deadly diseases puts children at risk of life-threatening diseases, says the World Health Organisation (WHO).
'The challenge now is how to improve vaccine delivery and uptake in areas of low coverage,' said lead author Dr Emily Haeuser.
She added that the world would miss the immunisation goals for 2030 without targeted, equitable immunisation strategies, alongside the strengthening of primary healthcare and efforts to tackle vaccine misinformation and hesitancy.
The World Health Organisation recommends a range of eleven three-vaccine combinations for all children globally, targeting polio, diphtheria, tetanus, pertussis, measles, mumps, rubella, tuberculosis, hepatitis B, Haemophilus influenzae type b (Hib), Streptococcus pneumoniae, rotavirus, varicella, etc.
Vaccine coverage between 1980 and 2023 has globally doubled against diphtheria, tetanus, whooping cough (pertussis), measles, polio, and tuberculosis, according to the report funded by the global vaccine alliance GAVI and The Gates Foundation.
Additionally, the number of children who never received a routine childhood vaccine—known as zero-dose children—declined globally by 75 percent between 1980 and 2019. Their number dropped from 5.68 crore to 1.47 crore just before the COVID-19 pandemic.
But since 2010, progress has stalled or reversed in many countries, with measles vaccination declining in 100 of 204 countries between 2010 and 2019. In 2023, an estimated 1.57 crore million zero-dose children had not received any doses of the diphtheria, tetanus, and pertussis vaccines in their first year of life, the report pointed out.
In India, under the Centre-run Universal Immunisation Programme, vaccines against 12 diseases are offered free of cost to all children, and in some cases, pregnant women at a specified age, via government hospitals.
In a rebuttal to a United Nations Children's Fund, which had shown a high number of zero-dose children in India last year, the Union health ministry had said the 'reports depict an incomplete picture of the country's immunisation data as they do not factor in the population base and immunisation coverage of the countries compared'.
ThePrint has reached out to Union Health Secretary Punya Salila Srivastava over email for a response to the report. This copy will be updated if and when a reply is received.
Independent experts ThePrint spoke with pointed at the disruption in routine immunisation services during the pandemic across health systems that prioritised COVID-19 care mainly. Traditionally, misinformation and vaccine hesitancy among some population groups have constantly remained barriers.
'The number of zero-dose children has been low in some tribal and other religious minority communities due to a reluctance to accept routine vaccines over the fear of serious side effects,' infectious disease specialist Dr Ishwar Gilada said.
India now needs to prioritise providing vaccination coverage to such groups, Gilada said, adding that it was paramount that people saw these figures in context, such as considering the population of India.
Also Read: Don't scratch mosquito bites. Here is how to deal with itching, redness
Countries with a huge vaccination gap
India has consistently featured among the countries with the highest numbers of zero-dose children.
According to the report, 53·5 percent of zero-dose children lived in five countries—India, China, Indonesia, Pakistan, and Bangladesh—in 1980.
By 2019, most of them—52.8 percent of zero-dose children—still lived in only seven countries, which are Nigeria, India, Ethiopia, the Democratic Republic of the Congo, Brazil, Somalia, and Pakistan.
The COVID-19 pandemic, which, in many areas, resulted in declining trust in public health institutions and polarised opinions on the necessity, as well as safety, of COVID-19 vaccines, has had varying effects on public perceptions regarding the importance of routine childhood vaccination and willingness to vaccinate, according to the report.
Substantial increases in coverage are necessary in many countries and territories, and those in sub-Saharan Africa and South Asia face the toughest challenges, the report noted.
(Edited by Madhurita Goswami)
Also Read: Eli Lilly announces trial results for world's 2nd weekly insulin, aims for launch by year-end
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
23 minutes ago
- New Indian Express
India among eight countries with half of world's unvaccinated children as of 2023: Study
NEW DELHI: India was among the eight countries where more than half the unvaccinated children from around the world lived as of 2023, an analysis published in The Lancet journal showed, "emphasising persistent inequities." Providing global estimates of current vaccine coverage, the study found that the same year, there were 15.7 million children -- 1.44 million in India -- who had received no doses of the diphtheria, tetanus, and pertussis vaccine in their first year. An international team of researchers forming the 'Global Burden of Disease (GBD) 2023 Vaccine Coverage Collaborators' updated global, regional, and national estimates of routine childhood vaccine coverage from 1980 to 2023 for 204 countries and territories. In 1980, 53.5 per cent of children who had never received a routine childhood vaccine, or 'zero-dose' children, lived in just five countries -- India, China, Indonesia, Pakistan, and Bangladesh --, they said. Routine childhood vaccinations are among the most powerful and cost-effective public health interventions available, said senior author Dr Jonathan Mosser from the Institute for Health Metrics and Evaluation (IHME), University of Washington, US, which co-ordinates the GBD study. "Despite the monumental efforts of the past 50 years, progress has been far from universal. Large numbers of children remain under- and un-vaccinated," Dr Mosser said. Persistent global inequalities, challenges due to the COVID-19 pandemic, and growth of vaccine misinformation and hesitancy have all contributed to faltering immunisation progress. The trends increase the risk of outbreaks that can be prevented through vaccinations, including measles, polio, and diphtheria, the senior author added.
Hans India
an hour ago
- Hans India
Rigorous health monitoring in place for Rath Yatra
Bhubaneswar: In preparation for the upcoming Rath Yatra, the Odisha government has announced a series of health measures, including the deployment of 378 healthcare professionals and 265 hospital beds to ensure public safety during the annual religious event in Puri. Talking to reporters, Health and Family Welfare Minister Mukesh Mahaling said elaborate arrangements have been made to handle medical emergencies during the festival, which draws lakhs of devotees each year. Mahaling said in addition to 378 doctors and para-medical staff, 69 first-aid centres and 74 ambulances will be kept ready for any emergencies. Given the recent outbreak of diarrhoea, the government has taken precautions to ensure the availability of safe drinking water and prevent the sale of stale food in the town. The additional 265 hospital beds include 15 ICU beds and 100 beds at the ANM Training Centre, while the Puri District Headquarters Hospital has reserved 68 beds, including general, burn and ICU facilities. 'I hope that the Rath Yatra will be conducted smoothly with the blessings of Lord Jagannath,' the minister said. The District Headquarters Hospital (DHH) has reserved 68 beds, including 50 general beds, 8 burn ward beds and 10 ICU beds, an official statement of Health department said. Additionally, 200 units of blood have been reserved while two minor operation theatres along with specialised dressing rooms have been set up to handle any medical emergencies. For the first time, a team of doctors from AIIMS-Bhubaneswar will be stationed at medical centres in Puri to provide additional support. Similarly, a specialised 10-bed air-conditioned heat stroke centre has been established at Talabania to address weather-related health issues. 'Rigorous health monitoring and disease prevention measures are in place to maintain public health standards throughout the Rath Yatra period,' the statement said. Eight food safety officers have been assigned the job to curb outbreak of any water or food-borne disease. All 108 emergency ambulances will remain on high alert and operate along designated corridors with the support of NGO volunteers. So far, 494 kg of unhygienic food has been destroyed after 249 inspections of food establishments. The administration has also collected 84 food samples, 22 water samples and conducted 10 stool culture tests and 82 water analyses. An extensive information, education and communication campaign will be undertaken to promote public health awareness covering food safety, safe drinking water practices, hand washing and hygiene protocols, ORS usage, health programmes, COVID-19 prevention measures and Ayushman Bharat Programme awareness, the statement said. A dedicated Rath Yatra control room will operate round-the-clock throughout the festival period to coordinate all health-related activities and respond to emergencies. The control room can be reached at mobile number +91 6370560247 and landline number 06752-222175 for any medical assistance or information.
&w=3840&q=100)
Business Standard
an hour ago
- Business Standard
Bharat Biotech, GSK to slash malaria vaccine price to $5 per dose by 2028
Drugmakers Bharat Biotech and GSK will cut the price of their malaria vaccine to $5 per dose by 2028, more than halving its current cost, they said on Wednesday. The vaccine, Mosquirix or RTS,S, was developed by GSK and the non-profit PATH, and was the first malaria vaccine to get approval from the World Health Organization in 2022. GSK is working on a technology transfer to Bharat, and will continue to supply the adjuvant part of the vaccine to Bharat when the Indian drugmaker fully takes over production of the shot by 2028. A phased reduction in price for the vaccine will begin immediately, GSK said in a statement with Bharat, reaching the target price of $5 by 2028. The price cut was "driven by process improvements, expanded production capacity, cost-effective manufacturing, and minimal profit margins," the statement read. Malaria kills more than 500,000 people annually, mainly children aged five and under in sub-Saharan Africa, according to WHO estimates. Cases and deaths fell significantly between 2000 and 2015, but progress has since stalled and even reversed, with a particular jump in mortality during the COVID-19 pandemic. Many experts have expressed hope that vaccines can help turn the tide in the fight against the mosquito-borne disease. But price has been an issue, particularly when compared to other tools to prevent malaria like bed nets. GSK has previously said it was committed to supplying up to 18 million vaccine doses between 2023 and the end of this year. The company plans to supply 15 million doses annually from 2026-2028, according to a spokesperson. Wednesday's announcement comes as Gavi - a global vaccine group that helps buy childhood vaccines in the world's poorest countries - holds an event in Brussels to raise funding for its work over the next five years, as governments pull back from international aid. GSK and Bharat said the price reduction showed their commitment to Gavi, which has been funding some of the roll-out of the malaria vaccine. Twelve African countries are set to introduce the vaccine in their routine immunisation programmes by the end of this year with Gavi's support. The other approved malaria vaccine, developed by the University of Oxford and the Serum Institute of India, is priced at under $4 a dose.
